A detailed history of Simplex Trading, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 2,902 shares of ADPT stock, worth $16,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,902
Previous 23,293 87.54%
Holding current value
$16,193
Previous $84,000 83.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$3.37 - $5.12 $68,717 - $104,401
-20,391 Reduced 87.54%
2,902 $14,000
Q2 2024

Jul 25, 2024

SELL
$2.34 - $3.96 $11,402 - $19,297
-4,873 Reduced 17.3%
23,293 $84,000
Q1 2024

Apr 25, 2024

BUY
$2.88 - $4.8 $73,725 - $122,875
25,599 Added 997.23%
28,166 $90,000
Q4 2023

Feb 02, 2024

BUY
$3.46 - $5.33 $8,881 - $13,682
2,567 New
2,567 $12,000
Q2 2023

Aug 04, 2023

BUY
$6.19 - $8.78 $40,835 - $57,921
6,597 Added 189.68%
10,075 $67,000
Q1 2023

Apr 27, 2023

BUY
$7.8 - $10.11 $11,895 - $15,417
1,525 Added 78.08%
3,478 $30,000
Q4 2022

Feb 02, 2023

BUY
$6.26 - $9.34 $5,421 - $8,088
866 Added 79.67%
1,953 $14,000
Q3 2022

Nov 04, 2022

BUY
$6.5 - $12.67 $7,065 - $13,772
1,087 New
1,087 $7,000
Q2 2022

Aug 03, 2022

SELL
$6.4 - $14.73 $26,464 - $60,908
-4,135 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$10.12 - $28.9 $32,707 - $93,404
3,232 Added 357.92%
4,135 $57,000
Q4 2021

Feb 23, 2022

BUY
$25.17 - $36.85 $5,285 - $7,738
210 Added 30.3%
903 $25,000
Q3 2021

Oct 28, 2021

BUY
$30.02 - $39.87 $12,008 - $15,947
400 Added 136.52%
693 $27,000
Q2 2021

Aug 12, 2021

SELL
$32.22 - $44.59 $282,440 - $390,875
-8,766 Reduced 96.77%
293 $11,000
Q1 2021

Apr 26, 2021

BUY
$37.26 - $67.74 $337,538 - $613,656
9,059 New
9,059 $364,000
Q1 2020

Apr 29, 2020

SELL
$16.96 - $34.16 $13,279 - $26,747
-783 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$24.56 - $32.8 $19,230 - $25,682
783 New
783 $23,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $797M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.